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During neurogenesis, complex networks of genes act sequentially to control neuronal differentiation. In the neural tube, the expression of
Pax6, a paired-box-containing gene, just precedes the appearance of the first post-mitotic neurons. So far, its only reported function in the
spinal cord is in specifying subsets of neurons. Here we address its possible function in controlling the balance between proliferation and
commitment of neural progenitors. We report that increasing Pax6 level is sufficient to push neural progenitors toward cell cycle exit and neuronal
commitment via Neurogenin 2 (Ngn2) upregulation. However, neuronal precursors maintaining Pax6On fail to perform neuronal differentiation.
Conversely, turning off Pax6 function in these precursors is sufficient to provoke premature differentiation and the number of differentiated
neurons depends of the amount of Pax6 protein. Moreover, we found that Pax6 expression involves negative feedback regulation by Ngn2 and this
repression is critical for the proneural activity of Ngn2. We present a model in which the level of Pax6 activity first conditions the moment when a
given progenitor will leave the cell cycle and second, the moment when a selected neuronal precursor will irreversibly differentiate.
© 2007 Elsevier Inc. All rights reserved.Keywords: Pax6; Neurogenesis; Spinal cord; Chick; MouseIntroduction
The vertebrate central nervous system is composed of a
multitude of functionally specialized cells that are derived from
a common pool of neural precursors. During spinal cord
maturation, neural progenitors go through several steps of
differentiation. At early stages, all progenitors proliferate and
are located in the ventricular zone (VZ) of the neural tube. Then,
through intrinsic and environmental signals, some of them are
selected to leave the cell cycle and start to express young
neuronal characters. These selected precursors exit laterally
from the ventricular zone to accumulate in the mantle layer
(ML) where they fully differentiate as mature neurons. Each
neural cell will follow this developmental scheme at a time
depending on its position along the antero-posterior (A–P) and
dorso-ventral (D–V) axis.⁎ Corresponding author. Fax: +33 5610556507.
E-mail address: belviala@cict.fr (S. Bel-Vialar).
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doi:10.1016/j.ydbio.2007.02.012The comprehension of the genetic control involved in this
general program of neurogenesis recently made a lot of
progress. The identification of proneural genes which encode
for bHLH transcription factors provided a good start in
understanding the molecular control of vertebrate neurogen-
esis. These families of genes, homologous to the achaete–
scute and atonal group of genes, first characterised in Dro-
sophila, are necessary and sufficient to confer a neuronal
identity to a neural progenitor (Bertrand et al., 2002). In vivo,
the ectopic expression of members of ato and Neurogenin
families in the surface ectoderm of Xenopus and zebrafish
embryos or in the neural tube of chick embryos drives
progenitor cells out of the cell cycle and promotes neuronal
differentiation (Blader et al., 1997; Kim et al., 1997; Lee et
al., 1995; Ma et al., 1996; Mizuguchi et al., 2001). At the
opposite, loss of function of proneural genes leads to the
reduction of at least some subsets of neurons (Fode et al.,
2000; Kim et al., 2001; Ma et al., 1998).
Linked to the proneural activity, lateral inhibition is taking
place to regulate the proportion of dividing progenitors that
leave the cell cycle and differentiate at each given position
660 S. Bel-Vialar et al. / Developmental Biology 305 (2007) 659–673(Louvi and Artavanis-Tsakonas, 2006). Expression of a
proneural gene in a cell leads to the upregulation of Notch
ligands (as Delta, Serrate) that interact with the Notch receptor
present at the surface of the neighbouring cells thereby
activating in the latter the expression of neurogenesis inhibitors
like some HES transcription factors (Chitnis et al., 1995; de la
Pompa et al., 1997). Hence, proneural genes restrict their own
activity to single cells and the balance between this proneural
activity and Notch activity will determine the time when a given
progenitor exits the cell cycle and moves into a differentiation
program (Louvi and Artavanis-Tsakonas, 2006). Positive feed-
back mechanisms will then contribute to stabilize the commit-
ment of progenitors to differentiation (Bertrand et al., 2002).
Finally, bHLH genes of the NeuroD family will be transiently
expressed in post-mitotic differentiating neurons preceding the
appearance of pan-neuronal markers such as βTubulin, HuC/D
or NeuN (Diez del Corral and Storey, 2001).
One important transcription factor involved at many dif-
ferent levels of specification and differentiation is the Paired
box gene Pax6. In the spinal cord, the initial analysis of the
Small eye (sey) mice, which carry a natural mutation in the Pax6
gene (Hill et al., 1991), revealed that Pax6 plays a role in the
specification of certain subtypes of ventral neurons. Indeed, in
the Pax6Sey/Sey mice, the neural tube patterning is altered
(Ericson et al., 1997b) and for example, the dorsal limit of
Nkx2.2, which is controlled by Pax6, is expanded dorsally
(Briscoe et al., 2000; Ericson et al., 1997b; Lei et al., 2006).
Following these patterning changes, the generation of V1 and
V2 subtypes of ventral interneurons is impaired and the
specification of subsets of motoneurons (MNs) is altered
(Ericson et al., 1997b). Moreover, in progenitors for ventral
motor neurons, the activity of Pax6 is critical for the expression
of the bHLH protein Olig2 that plays a pivotal role in
motoneuron differentiation and specification (Lee et al., 2005;
Mizuguchi et al., 2001; Novitch et al., 2001). In the chick,
Pax6 is detected from the 4-somite stage in the spinal cord
primordium and extends caudally in a head to tail sequence
accompanying neural tube elongation and maturation (Gould-
ing et al., 1993; Li and Noll, 1994). At the onset of its
expression Pax6 transcripts are found in all neural progenitors
in the dorso-ventral axis, only excluded from the roof plate and
the floor plate (Goulding et al., 1993; Ericson et al., 1997b). Its
domain of expression is then progressively restricted to the
intermediary zone following negative influences by BMP and
Shh molecules secreted from the dorsal and ventral parts of the
neural tube, respectively (Pituello, 1997). Pax6 activation is
controlled by the signalling pathways that regulate neuronal
differentiation. Hence, Pax6 is absent from the caudal neural
plate, containing the stem cell zone (Akai et al., 2005; Mathis
et al., 2001) being repressed there by FGF signalling which
keeps neural progenitors in the cell cycle and prevents
precocious neuronal differentiation (Bertrand et al., 2000;
Diez del Corral et al., 2003; Lobjois et al., 2004; Pituello et al.,
1999). Then, Pax6 is activated in the closing neural tube by
retinoic acid signalling concomitantly with the activation of
neuronal determinants (Diez del Corral et al., 2003; Novitch et
al., 2003).Recent data suggest that Pax6 could be involved in neuronal
commitment in the spinal cord: Indeed, Pax6 positively controls
some aspects of the proneural gene Ngn2 expression in the
mouse spinal cord (Scardigli et al., 2001) and this regulation is
direct and dependent to the level of Pax6 protein (Scardigli et al.,
2003). Furthermore, analysis of Pax6sey/sey mice shows that
Pax6 delays the time of emergence of some motoneurons (Sun et
al., 1998). As Pax6 is initially activated in most neural
progenitors at a time just preceding neuronal differentiation
but is in the same time restricted to proliferating progenitors, we
decided to investigate Pax6 function in the time frame of early
neuronal differentiation in details. By gain and loss of function
experiments in the chick neural tube, we found that the threshold
of Pax6 protein is critical for cell cycle exit and neuronal
commitment. Once neural progenitors are committed to a
neuronal program, Pax6 protein has to be turned off to allow
neuronal differentiation. Moreover, loss of function experiments
in chick or mouse embryos reveal that the absence of Pax6 leads
to precocious neuronal differentiation. Finally, we show that the
downregulation of Pax6 expression can be controlled by high
levels of Ngn2. Our conclusions support a role for Pax6 in
maintaining neuronal precursors in a “pre-differentiation” state
by counteracting the proneural activity of Ngn2.Materials and methods
Embryos
Fertile hen's eggs obtained from a local supplier were incubated at 38 °C in a
humidified incubator for appropriate periods to yield embryos of stage 9–11
(Hamburger, 1992).
Mouse embryos in which Pax6 is replaced by β-Galactosidase (Pax6–LacZ)
were obtained from P. Gruss (St-Onge et al., 1997) and propagated by hete-
rozygous mating. E8.5 to 10.5 dpc embryos were used for the analyses and were
genotyped by PCR performed on the yolk sac. The midday of the vaginal plug
was designated as 0.5 day of development. The following experimental
procedures were done in agreement with the French regulation concerning
animal experimentation.
Electroporation of DNA
The different DNA constructs were electroporated on the left side of the
neural tube of stage HH10 chick embryos as described in (Itasaki et al., 1999).
The Pax6 constructs are derived from Dr Nakamura (Matsunaga et al., 2000);
Pax6, Pax6VP16 and Pax6EnR cDNAwere cut from pMiw plasmid and recloned
in the pCIG plasmid (Megason and McMahon, 2002). Pax6 was also cloned in
the mammalian vector pECE (Ellis et al., 1986) with or without an IRES–GFP.
Control experiments have been performed by electroporation of the pCIG vector
alone. Pax3 was cloned in the PcS2 vector. The Ngn2–Flag version of chick
Ngn2 is a gift from P. Charnay (Garcia-Dominguez et al., 2003); XNotch ICD,
XDelta and XDeltaSTU from Chitnis et al. (1995); Nkx2.2 fromD. Rovitch (Sun
et al., 2001).
In situ hybridisation and immunohistochemistry
In situ hybridisation was performed as described (Bel-Vialar et al., 2002).
Riboprobes have been synthesised from isolated specific PCR fragments to
avoid any corresponding plasmid regions in the probes and suppress regions of
putative cross reactivity between the probes or probes and transgenes (sequences
of primers used are available on request). Pax6 probe is described in Pituello et
al. (1995), NeuroM plasmid is a gift from T. Roztocil (Roztocil et al., 1997), C-
Delta-1 and Sox2 a gift from D. Henrique (Henrique et al., 1995), cNgn2 a gift
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Guillemot (Gradwohl et al., 1996).
Immunohistochemistry was performed as described (Lobjois et al., 2004).
Embryos were fixed 2 h in 4% paraformaldehyde at 4 °C. Stage HH10 embryos
and E8.5–9.5 dpc staining were performed on whole mount. For older embryos
the spinal cord was transversally sectioned in 45 μm slices with a vibratome
(Leica VT1000S) before immunohistochemistry. Detailed references of used
antibodies are available as a Supplementary material. Analyses were done with a
Leica TCS SP-2 spectral confocal and a multiphoton microscope. Analysis of
apoptosis was performed using an In Situ Cell Death detection kit (Roche).
Cell proliferation analysis
For proliferation analysis, 20 μl of bromodeoxyuridine (BrdU, 10 μg/μl) are
deposed on the chorioallantoic membrane of electroporated embryos and
incubated 30 min before fixation. Cells in mitosis were visualized using an anti
phospho-histone H3 (H3P). The percentages of transgenic neural precursor cells
in S- and M-phase were determined by counting the number of total GFP nuclei
per section and the number of nuclei expressing both GFP and BrdU or both
GFP and H3P on optic confocal sections of 5 μm thickness.
Quantification analysis in the chick experiments
The data represent mean±S.E.M. of cell counts and correspond to the
analysis of 3 to 5 sections of at least 6 embryos processed in 3 to 5 independent
experiments for each conditions (more than 2000 cells counted for each
condition).
Results
Increasing Pax6 levels induces Ngn2 but is not sufficient to
initiate neuronal differentiation
It was previously established that Pax6 upregulates Ngn2
levels in the neural tube, suggesting that Pax6 may control
neuronal commitment (Scardigli et al., 2003). The activation
of Ngn2 in neural progenitors precedes the final mitosis and
is followed closely by an increased expression of cDelta-1
and NeuroM (Henrique et al., 1995; Murciano et al., 2002;
Roztocil et al., 1997). Pax6 is expressed in proliferating
progenitors and its expression is extinguished as neuronal
precursors differentiate (Supplementary Fig. 9). In the Pax6
expression domain, we consistently observed that the level of
Pax6 protein is not identical in all cells (Supplementary Fig.
9) raising the possibility that these differences may be critical
for neuronal commitment. We thus cloned Pax6 in two
different vectors allowing to express either high level (Pax6–
IRES–nuclearGFP construct in pCIG (Megason and McMa-
hon, 2002) referred here as Pax6high) or low level of Pax6
(Pax6 in the pECE vector referred as Pax6low (Ellis et al.,
1986; Stamataki et al., 2005); see levels of transgenes in
Supplementary Fig. 9). Transgenic embryos were checked for
Ngn2, cDelta-1 and NeuroM expression 6 h following
electroporation. As anticipated, Ngn2 was quickly upregulated
in the electroporated zone with Pax6high (Figs. 1A–D; n=8/8)
but this induction was clearly less efficient when Pax6low was
used as only 2/10 embryos upregulated Ngn2 (Figs. 1I–K).
However, we could not detect any upregulation of either
cDelta-1 (Figs. 1E, F; n=0/5) or NeuroM expression (Figs.
1G, H; n=0/5) suggesting that Pax6high cells did not progress
in neurogenesis in response to Ngn2 upregulation. Toascertain that cells in the caudal neural groove were com-
petent to engage in neuronal differentiation, we transfected a
Ngn2–flag construct (Garcia-Dominguez et al., 2003) and
checked 5 h after for cDelta-1 and NeuroM expression. Both
cDelta-1 and NeuroM were strongly induced by Ngn2
electroporation (Figs. 1L, M; n=6/6 and Figs. 1N, O; n=
3/3). These results indicate that the amount of Pax6 protein is
critical to induce neuronal commitment. However, caudal
neural precursors fail to initiate neuronal differentiation when
maintaining Pax6 expression, even in conditions of high
levels of Ngn2.
Neural cells maintaining Pax6 expression never become
neuron
In order to check if neuronal differentiation was blocked or
only delayed following Pax6 misexpression, we looked at
neuronal markers 24 h or 40 h following Pax6high or Pax6low
electroporation. After 24 h, transgenic neural precursors did not
succeed in inducing cDelta-1 and NeuroM and the expression of
these two genes is downregulated following Pax6high electro-
poration (Supplementary Fig. 10). Olig2 was similarly
decreased in these experimental conditions (Supplementary
Fig. 10). Moreover, Ngn2 that was upregulated earlier was not
maintained in transfected cells (Supplementary Fig. 10).
Consequently, the expression of the neuronal protein βTubulin
was strongly reduced when using Pax6high (Figs. 2A, B; n=
8/8). A milder phenotype was observed if Pax6low was used
(Figs. 2C–F) as we could detect a slight reduction of βTubulin
and Ngn2 expression in the electroporated zone (Figs. 2C–D
and Supplementary Fig. 10). This phenotype is cell autono-
mous as with both constructs, none of the Pax6 transgenic cells
did express βTubulin (Figs. 2A, D, E) as checked by
quantifying the number of transgenic βTubulin cells (Fig.
2G). The same results were obtained by expressing an activator
form of Pax6 made of the paired domain and homeodomain of
Pax6 fused to the transactivation domain of VP16, indicating
that Pax6 acts as a transcriptional activator in this context (not
shown). After 40 h, in embryos transfected with Pax6high, we
observed some GFP+Pax6+ cells positioned in the mantle
region among differentiating neurons, indicating that Pax6high
cells can migrate out of the ventricular zone (Figs. 2L, N;
n=10/10). Although these cells located in the differentiation
zone do not retain the expression of the young neural protein
Sox2, (Figs. 2U, V) they do not switch on the pan neuronal
HuC/D (see patches of GFP+HuC/D− cells in the middle of
GFP−HuC/D+ cells in Fig. 2N). The use of a nuclear neuronal
marker, NeuN, to quantify the number of mature neurons
within the transgenic population (Figs. 2O, P), confirms that
even after a longer term, none of the Pax6high cells
differentiated as neuron (Fig. 2H). Using Pax6low, the size of
HuC/D domain was also reduced compared to the control side.
However, while many GFP+Pax6off cells (GFP produced by the
co-injected vector peGFP) did migrate out of the ventricular
zone and expressed HuC/D (Figs. 2Q–T) we could not detect
any Pax6low cells in the differentiation field. This suggests that
the Pax6low transgenic cells did not migrate out of the
Fig. 1. Neurogenesis progression is blocked after the initial step of Ngn2 activation following Pax6 overexpression. Pax6High overexpression leads to the upregulation
of Ngn2 in 6 h (A–D) but does not modify the expression pattern of cDelta-1 (E, F) or NeuroM (G, H) transcripts. Pax6Low overexpression leads to Ngn2 upregulation
in only 2/10 embryos (one of the two induced embryos is shown in panels I–K). The transfection of Ngn2–Flag is sufficient to upregulate the expression of cDelta-1
(L, M) and NeuroM (N, O) in 6 h.
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transgenic cells expressed HuC/D after 40 h of incubation
(Figs. 2Q–T) indicating that neuronal differentiation is also
impaired when maintaining low levels of Pax6 protein in neural
precursors. All together, these observations were indicative of a
persistent block of neuronal differentiation in neural precursors
maintaining Pax6On.
High levels of Pax6 affect proliferation of neural progenitors
The neuronal block we observed was accompanied by a
severe reduction of the neural tube size following injection with
Pax6high (Figs. 2B, L). We checked the apoptotic status of
electroporated cells by TUNEL analysis and we could not detect
differences in the number of dying cells between the
electroporated and the non electroporated sides (Supplementary
Fig. 11). As we could not detect any increase in apoptosis, the
narrowing of the neural tube was suggestive of a proliferation
defect and prompted us to analyse the proliferation and mitotic
indexes in the transgenic population by BrdU incorporation and
histone 3-phosphorylated (H3P) staining. Following Pax6high
injection, we observed a global reduction of H3P and BrdU
staining whereas the injection of Pax6low did not affect
proliferation (Supplementary Fig. 11). We quantified in each
experimental conditions the number of BrdU- or H3P-positive
cells among the transfected population (Figs. 2I, J). The number
of cells in S phase was strongly reduced following Pax6highinjection (Fig. 2I; n=9), with only 8.5% of the transfected cells
incorporating BrdU, while 30% of Pax6low and 27% of control
transfected cells incorporate BrdU (n=5 and n=9). Similarly,
we measured a 3-fold decrease in the mitotic index of Pax6high
cells (Fig. 2J; n=8) indicating that cell cycle progression was
globally affected. Hence, while high levels of Pax6 affect the
proliferation of neural progenitors low levels of Pax6 do not.
This suggests that increasing Pax6 levels is a mean to direct
selected neuronal precursors toward cell cycle exit by way of
Ngn2 activation.
Reversal of the neuronal block in transgenic cells that are
losing the Pax6 protein
Our results so far show that following Pax6-mediated Ngn2
induction, neuronal differentiation is blocked in neuronal
progenitors maintaining Pax6On. If maintenance of Pax6 is
the only reason for which neuronal differentiation cannot occur,
switching it off should be sufficient to reverse the neuronal
block. We therefore asked what would happen in a transgenic
cell maintaining Pax6On during 24 to 48 h and then turning off
Pax6 protein. To answer this question, we took advantage of the
fact that electroporation is a transient mean of expression. The
GFP protein being more stable than the Pax6 protein, we should
find a time window when some transgenic cells have
extinguished Pax6 protein but retained GFP expression. We
constructed a pECEPax6 vector now linked to an IRES–GFP
Fig. 2. Maintaining Pax6On is incompatible with neuronal differentiation.βTubulin (A–G), HuC/D (K–N andQ–T) and NeuN (H, O, P) immunodetections 24 h (A–G)
or 40 h (K–T) after electroporation show that Pax6 transgenic cells do not differentiate as neuron. Note that none of the Pax6high cells in (panels L, N) are HuC/D-positive
whereas most of the GFP cells in this location are HuC/D-positive following electroporation of the control vector (compare panels M and N). Note that transgenic cells
expressing Pax6Low are βTubulin-negative (D, F) and HuC/D-negative (Q–T) whereas several co-injected transgenic cells expressing only GFP but not Pax6 express
βTubulin (C, E) andHuC/D (Q–S). Proliferation andmitotic indexes are strongly decreasedwith Pax6high but not with Pax6low (I, J). Data are mean±S.E.M. In the BrdU
histogram (I); Student's test, *P<0.001=highly significant; **P<0.1=not significant. In the H3P histogram (J); *P<0.001=highly significant. See also Figs. S9 and
S10. After 40 h of incubation, Pax6high transgenic cells that migrated in the differentiating field do not express Sox2 anymore (U, V; arrow).
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expressed the Pax6 protein earlier. As already seen with the
Pax6low construct, cells expressing the Pax6low–GFP construct
do not differentiate as neuron when analysed 24 h after
electroporation (Figs. 3A–F). After 50 h of incubation, we
detect many GFP+ transgenic cells that have lost the expression
of Pax6 protein and these cells do now express the βTubulin
(Figs. 3G–L). We observed a good correlation between the
GFP+PAX6off status and the expression of βTubulin as
transgenic GFP+ cells, in which Pax6 protein expression
persists, remain βTubulin-negative. Hence, neuronal precursors
that are artificially blocked in a non-differentiated state for a
long period of time are able to reverse their phenotype and to
differentiate into neuron as Pax6 transgenic protein goes down.
This strongly suggests that Pax6 acts to maintain selected
neuronal progenitors in an immature “pre-differentiated” state.
Turning off Pax6 in the ventricular zone leads to premature
neuronal differentiation
If Pax6 works to keep selected neuronal precursors in a non
differentiated state, removing Pax6 function prematurely in
neuronal precursors should lead to a precocious neuronal
differentiation. To test that idea further, we used a dominantnegative form of Pax6, construct linking the HD and paired
domain of Pax6 to the repressor domain of the chick engrailed
gene (Pax6EnR) (Matsunaga et al., 2000). We chose to over-
express Pax6EnR in the neural tube at HH10. At this stage, many
neural precursors located in the ventricular zone already express
Pax6 and Ngn2. Thus, the expression of Pax6EnR should
repress Pax6 targets in proliferating uncommitted progenitors as
well as in post-mitotic neuronal precursors. We first examined
the embryos 24 h after electroporation and observed an
accumulation of the βTubulin (Figs. 4A–C; n= 12/12) and
HuC/D in the ventricular zone (Figs. 4D–F; n=6/6), when
βTubulin- and HuC/D-positive cells are only detected lateral to
this zone in a wild type situation or following the electropora-
tion of the GFP-tagged control vector (not shown; n=8). When
quantified, the number of GFP+βTubulin+ cells was increased
from 5% with a control vector to 16.5% in the Pax6EnR
population (Fig. 4Q). Moreover, we detected Pax6EnRGFP+
cells co-expressing p27 (marker of G0 phase) in the ventricular
zone (Figs. 4G–J; n=3), suggesting that these cells passed
through the G0 phase of the cell cycle prematurely. At the same
time, the expression of Ngn2 is strongly reduced, probably
reflecting a reduction of the neuronal precursors pool and
consequently, the number of cDelta cells is also slightly reduced
(Supplementary Fig. 12).
Fig. 3. Transgenic cells losing Pax6 expression perform neuronal differentiation. Stage HH10 chick embryos were electroporated with the Pax6low–GFP construct.
24 h following electroporation, most of the transgenic cells co-express the GFP and the Pax6 protein (A–F) and none of these cells do express the βTubulin
(arrowheads). When the embryos are incubated longer, some transgenic cells are losing the expression of Pax6 whereas still expressing the GFP protein which is more
stable (G–L). These cells are no more blocked in an immature state and now express the βTubulin protein (see the group of GFP+PAX6−βTub+ cells surrounded with
dash points in panels J, K, L). Note that transgenic cells that still retain Pax6 expression do not turn on βTubulin (arrows in panels J, K, L).
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be the consequence of a migration defect and/or could reflect a
premature neuronal differentiation due to the repression of Pax6
targets in selected precursors. To distinguish between these two
possibilities, we analysed the position of GFP cells 48 h after
electroporation. At this stage, cells transfected with the GFP-
tagged control vector were detected throughout both the
ventricular zone and the mantle layer (Fig. 4K) whereas in a
subset of Pax6EnR-transfected embryos, most GFP+ cells had
migrated out of the ventricular zone (Fig. 4L). We then
measured the proliferative index of transfected cells, assuming
that a migration defect would not affect this parameter whereas
a premature differentiation would reduce the size of the pool of
proliferating progenitors. Following electroporation with the
Pax6EnR construct, the mitotic index was not significantly
changed (Figs. 4O, P, Q) but we observed a significant reduction
of the pool of cells in S phase (Figs. 4M, N, Q; n=7; 19% of
Pax6EnR cells are BrdU+) as expected if neural progenitors are
pushed prematurely out of the cell cycle to differentiation.
Hence, the preferential location of Pax6EnR in the mantle layer
reflects a premature exit of the cell cycle and differentiation. The
co-expression of Pax6 with Pax6EnR abolished the accumulation
ofβTubulin induced by Pax6EnR alone while co-expression with
Pax3 could not (Supplementary Fig. 13), confirming the
specificity of the phenotype (Pax3 itself having a weak or no
effect on neuronal differentiation, Supplementary Fig. 13). On
the contrary, the co-injection of Nkx2.2 reverses the precocious
neuronal differentiation induced by Pax6EnR but Nkx2.2 also
blocks neuronal differentiation when injected alone, suggesting
that it is acting itself at another level of neuronal differentiation
(not shown). In conclusion, active repression of Pax6 targets is
sufficient to induce neuronal differentiation.Analysis of Pax6 mutant mice reveals a dose-dependant role
for Pax6 in early neuronal differentiation
All together our previous data suggest that Pax6 is able to act
on the onset of neurogenesis by increasing Ngn2 levels but also
to control the timing of neuronal differentiation by keeping
neuronal precursors in an undifferentiated state. We thus
wondered what would happen in a context where Pax6 protein
is totally absent. Analysis of Pax6 mutant mice already revealed
that Pax6 is involved in some aspect of neuronal specification in
the spinal cord (Ericson et al., 1997b). However, these studies
have been done on 10 dpc embryos, i.e. too late to identify a
putative function of Pax6 at the onset of neurogenesis.
Therefore, we decided to perform a careful analysis of the
Pax6–LacZ mutant mice (St-Onge et al., 1997). We first
confirmed that the staining of Islet-1 (motoneurons marker) was
reduced at 9.5 and 10.5 dpc in this Pax6–LacZ mouse strain, as
described for the Pax6sey mutant (not shown). We then
concentrated on early stages (between 8.5 and 9.5 dpc) focusing
on neuronal commitment (Ngn2 expression) and neuronal
differentiation (βTubulin expression).
We first compared the Ngn2 transcripts at 8.5 dpc and saw
that the overall pattern of Ngn2 expression is the same in all
the littermates from Pax6–LacZ heterozygous intercrosses
(Figs. 5A–C). In particular, the rostro-caudal extension of
Ngn2 is not altered suggesting that Pax6 is dispensable for
initiating Ngn2 transcription (Figs. 5A–C, F, I, L; Leroux,
personal communication). However, when analysed in detail,
we observed a clear reduction of the transcript in the posterior
hindbrain (Figs. 5D, G, J) and in the dorsal aspect of the
prospective cervical spinal cord (Figs. 5E, H, K) while the
caudal region is not significantly affected (Figs. 5F, I, L). At
Fig. 4. Blocking Pax6 targets in the ventricular zone leads to premature neurogenesis. The overexpression of Pax6EnR leads to an increase of βTubulin (A–C and Q);
HuC/D (D–F) and p27 expression (G–J) 24 h following electroporation. Compare the position of GFP cells 48 h following electroporation of the GFP-tagged control
vector (K) or the Pax6EnR construct (L). BrdU incorporation experiment (M, N) shows that proliferation rate is reduced in Pax6EnR-injected neural tubes. Quantification
of the percentage of electroporated cells that have incorporated BrdU, express H3P or express βTubulin (Q). Data shown are mean±S.E.M.; *P<0.001, student's test.
Following Pax6EnR injection, 19% of cells are BrdU+ instead of 28% following control injection, 16.5% express βTubulin instead of 5% following control injection.
The analysis of H3P expression does not reveal significant change of the mitotic index (O, P, Q) in Pax6EnR-electroporated neural tubes.
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expression (Figs. 5M–R) which now extends to the brachial
region (Figs. 5Q–R) but the domains of expression remain
almost unchanged (Figs. 5M, R). These observations suggest
that even if Pax6 regulates some aspect of Ngn2 transcription,
at these early stages, a large part of Ngn2 expression seems
independent of Pax6. Therefore, if our prediction is true,
having at 8.5 dpc in the absence of Pax6 an almost normal
Ngn2 level in the ventral part of the neural tube should give
rise to a precocious neuronal differentiation. We thus analysed
neuronal differentiation by looking at βTubulin expression at
8.5 dpc, which corresponds to the stage when the first
differentiated neurons appear in the spinal cord. To perform an
accurate quantitative analysis, we compared the number of
βTubulin cells in littermate embryos displaying the same
number of somites (Figs. 5S–V), the number of differentiating
neurons growing rapidly at that age. At 8.5 dpc we detected a
clear advance in neuronal differentiation in the absence of
Pax6. Indeed, βTubulin cells are already detectable in Pax6−/−
embryos from 7-somite stage whereas we could not detect anyβTubulin cells before 8-somite stage in the wild type or
heterozygous littermates (Fig. 5V). At the 10-somite stage, we
still have more neurons that are produced in the Pax6 homo-
zygous embryos if compared to the wild type and hetero-
zygous embryos (Figs. 5S–V). Moreover, we detected a clear
difference in the number of βTubulin-expressing cells
between heterozygous and wild type littermates revealing
the importance of Pax6 levels for this aspect of its function.
When we looked at 9.5 dpc, we could not detect any obvious
change in the number of βTubulin cells between heterozygous
or homozygous (not shown) but the analysis is rendered
difficult due to the huge amount of differentiated cells at this
stage. We concluded that at 9.5 dpc, either the phenotype is
compensated by some other mechanisms or the decrease of
Ngn2 expression leads to a reduction of the number of
selected neuronal precursors counterbalancing the premature
neuronal differentiation due to Pax6off. All together these
analyses in young mouse embryos confirm the data we obtained
in the chick embryo showing that Pax6off absence leads to
precocious neuronal differentiation. This also brings light to the
Fig. 5. Removal of Pax6 function favour neuronal differentiation in a dose-dependant manner. Mice embryos of 8.5 dpc (A–L and S–U) or 9.5 dpc (M–R) hybridised
with mNgn2 presented as whole mount (A–C and M, N) or 45 μm vibratome transversal sections (D–L and O, R). At 8.5 dpc, the overall expression of Ngn2 is not
severely affected in the Pax6 mutant (A–C). The staining is not affected in the caudal part of the embryo (F–L), a clear reduction of the transcript is seen in the dorsal
aspect of the cervical neural tube (E, H, K) and all over the structure in the posterior hindbrain (D, G, J). At 9.5 dpc, levels of transcripts are still reduced in the cervical
region of the neural tube (O, P) but also in the brachial region (Q, R). (S–U) are flat mounted neural tubes from 10-somite stage embryos (8.5 dpc). We detect a
progressive augmentation of the number of βTubulin-positive cells as copies of the Pax6 transcripts are removed (U, T, S). Graph V presents the number of βTubulin-
positive cells in the neural tube of WT, heterozygous or homozygous embryos depending of the number of somites of the embryos. Data shown are mean±S.E.M.;
number of embryos counted is between 3 and 5 except for homozygous 8-somite stage embryos, n=2. sm, somites.
666 S. Bel-Vialar et al. / Developmental Biology 305 (2007) 659–673fact that the function of Pax6 is dosage-dependant, as for its other
functions in eye development (Hill et al., 1991; Schedl et al.,
1996).
High levels of Ngn2 downregulate in feedback Pax6 expression
Having shown that downregulation of Pax6 activity in cells
following Ngn2 activation is a prerequisite to neuronaldifferentiation, the next question was how is Pax6 expression
downregulated in committed precursors? One possibility was
that it could be part of the proneural activity of Ngn2. Moreover,
Notch signalling could be directly involved as it is linked to
proneural activity and has been shown to control Pax6
expression in other systems (Kumar and Moses, 2001; Onuma
et al., 2002). We therefore expressed Ngn2 and different
components of the Notch signalling pathway known to interfere
667S. Bel-Vialar et al. / Developmental Biology 305 (2007) 659–673with lateral inhibition (Chitnis et al., 1995). XNotchICD and
XDelta maintain neural cells in an undifferentiated state;
XNotchICD being an activated form of Notch and XDelta
because it overstimulates the Notch receptor. XDeltaStu is a
truncated form of XDelta unable to contact the Notch receptor,
provoking massive neuronal differentiation. We electroporated
these different constructs in the neural groove of HH10 embryos
and checked 6 h after for Pax6 expression, considering that a
direct downregulation should be a rapid event. We detected a
clear repression of Pax6 transcripts in cells electroporated with
the Ngn2–Flag construct (Figs. 6E–J; n=4/4) whereas we
could not see any significant change following XNotchICD
injection (Figs. 6A, B; n=8/10; 2/10 showed a weak re-
pression), XDelta injection (Figs. 6C, D; n=0/9) or XDeltaStu
injection (not shown, n=0/7). After 24 h following Ngn2
overexpression, Pax6 endogenous expression was still stronglyFig. 6. High levels of Ngn2 downregulate Pax6 expression. The expression of Pax6
after 6 h (C, D) whereas Ngn2 overexpression leads to a rapid decrease of Pax6 transc
the ventricular zone (K, L) and this is correlated with a strong decrease of Pax6 proreduced (Figs. 6K, M) and this was correlated with a premature
expression of βTubulin (Figs. 6K, L). These results indicate that
high levels of Ngn2 are sufficient to extinguish Pax6 expression
in committed neuronal precursors. This effect could be indirect
and go through NeuroM which is rapidly upregulated upon
Ngn2 electroporation (see Fig. 1). Moreover, the fact that Ngn2
but not XDeltastu rapidly represses Pax6 expression suggests
that turning off Pax6 function is a rapid and critical event
required to perform neuronal differentiation following Ngn2
induction and is not an indirect consequence of lateral
inhibition.
Pax6 counteracts Ngn2 proneural activity
The fact that Pax6 protein repression by Ngn2 is closely
linked to the induction of neuronal differentiation suggested thattranscripts is not affected by the electroporation of XNotchICD (A, B) or Xdelta
ripts (E–J). Ngn2 injection provokes the accumulation of βTubulin after 24 h in
tein (K, M).
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of Ngn2. We therefore tested the possibility that high levels of
Pax6 could block Ngn2 ability to induce neuronal differentia-
tion. The co-expression of Pax6 and Ngn2 leads to a reduction
of βTubulin expression (Figs. 7G–I) instead of its accumulation
when misexpressing Ngn2 alone (Figs. 6K, L and 7A–C).
Hence, the resulting phenotype mimics the one of injecting
Pax6 alone (Figs. 7D–F). We therefore concluded that the
proneural activity of Ngn2 is counteracted by high levels of
Pax6 expression.
Discussion
In this study, by using both chick and mouse to perform
either gain or loss of function experiments in early embryos, we
reveal a new dosage-dependant function of Pax6 in controlling
the timing of neuronal differentiation. We show that, if Pax6
function is dispensable for Ngn2 expression, it contributes to
raising the level of that proneural factor in a dose-dependant
manner, thus participating in the commitment of neural
progenitors to a neuronal fate. However, the presence of Pax6
at any level in committed neuronal precursor precludes theirFig. 7. Pax6 counteracts the proneural activity of Ngn2. After 24 h, cells
electroporated with Ngn2 accumulate high levels of βTubulin in the
proliferating zone (A–C). Conversely, cells injected with Pax6high do not
express βTubulin (D–F). When Pax6 is co-injected with Ngn2, it blocks the
capacity of Ngn2 to induce neuronal differentiation (G–I).differentiation, suggesting that switching off Pax6 is a gate for
timing neuronal differentiation. We also demonstrate that Ngn2
is able to downregulate Pax6 in feedback and this may be an
important part of its proneural activity. All together, our data
show that the generation of neurons from neural progenitors
involves fine cross regulations between Pax6 and Ngn2
proteins.
A Pax6 protein threshold is critical for the activation of Ngn2
and proliferative behavior of neural progenitors
We have investigated the role of Pax6 in neuronal commit-
ment considering that the amount of Pax6 protein could
be of capital importance. We show that Pax6 is able to
upregulate Ngn2 in neural progenitors and this upregulation is
dose-dependent. Indeed, in the chick the upregulation of Ngn2
with Pax6low was poorly efficient whereas this upregulation was
observed in all embryos electroporated with Pax6high. This
reflects the need of a certain threshold of Pax6 to induce Ngn2
and with the pECE vector such critical threshold is more
randomly reached than with the pCIG vector, explaining the
variability of the phenotype. These experiments done in the
chick and in another published data (Scardigli et al., 2003)
clearly show that Pax6 is able to regulate several aspects of
Ngn2 expression at early stages. However, we only observed a
moderate downregulation of Ngn2 transcripts in Pax6 mutant
mice. This could be due to redundant activity performed by
other genes in the absence of Pax6. Alternatively, Pax6 function
may be dispensable for Ngn2 activation and be required only to
reinforce Ngn2 levels and thus neuronal selection. In this case,
maintaining high levels of Ngn2 expression could be critical at
some stage to allow a sufficient number of neural progenitors to
commit toward a neuronal fate (Fig. 8). In parallel with this
Ngn2 upregulation, Pax6high cells show a strong reduction of
cell proliferation. However, Pax6+ neural cells do not express
p27 at the stages we studied (Supplementary Fig. 9) and
transgenic Pax6high cells do not turn on p27 (not shown)
suggesting that they did not exit the cell cycle. A decrease in
proliferation has also been reported following injection of high
levels of Pax6 in glioblastoma cells and in that context, the
decrease is associated with a block in G1 phase of the cell cycle
(Zhou et al., 2005). This opens the possibility that in our
experimental context, even if they engaged toward cell cycle
exit, Pax6high cells may not have succeeded to reach the G0
phase and could have been blocked instead in some phase of the
cell cycle.
Switching off Pax6 function allows to progress in the
differentiation program
Our loss of function experiments done in the chick and
mouse embryos lead us to propose that in the embryonic spinal
cord, “Pax6off” is a gate for timing neuronal differentiation
(Fig. 8). In Pax6 loss of function mutant mice, different
phenotypes linked to the timing of neuronal differentiation
have been observed which depend of the cellular context. In
the eye, numerous neurons differentiate precociously in the
Fig. 8. Modulating Pax6 levels controls different steps during early neurogenesis. (A) Pax6low cells correspond to proliferating neural progenitors. The level of Pax6
protein progressively increases, up to a critical threshold sufficient to increase Ngn2 expression and direct neural progenitors toward cell cycle exit and neuronal
commitment. These Pax6high Ngn2low neuronal precursors are maintained in the “pre-differentiation” phase while progressively reaching high levels of Ngn2
expression and switching on NeuroM. When a certain threshold of Ngn2 is reached, Ngn2 downregulates Pax6 in feedback enabling NeuroM enhancement and the
irreversible commitment of precursors to neuronal differentiation. (B) Double immunostaining of Pax6 (A) with Ngn2 protein (B–D) or NeuroM (E–G) proteins on
45 μm vibratome sections from stage 18 chick embryos. As predicted by our model, inside the Pax6 domain we detect cells expressing only Pax6 protein (red staining
only); some cells being Pax6Med Ngn2Low (arrowheads); Pax6High Ngn2Med (arrows, rarely observed) or Pax6Low/Off Ngn2High (surrounded with dash point). The same
kind of ratio are seen if Pax6 is compared to NeuroM (Pax6OffNeuroMHigh surrounded with dash point and Pax6low NeuroMMed shown with arrowheads). Note that
most of the cells at the border between the ventricular and the mantle zone and in the process of differentiation are Ngn2High NeuroMMed and are extinguishing Pax6
protein.
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ectopic neurons are accumulated in the ventricular zone at E19
when this zone normally contains only proliferating progeni-
tors (Caric et al., 1997). Moreover, a recent study showed that
Pax6 acts early and autonomously in the cortex to prevent
precocious differentiation and depletion of the progenitor pool
(Quinn et al., 2007). In the mutant spinal cord, most neurons
are generated correctly but motoneurons and the few V1
interneurons that are formed appear at later stages than normal
(Ericson et al., 1997b; Sun et al., 1998). In the present study,
we show that in the absence of Pax6, neuronal differentiationoccurs prematurely in the 8.5 dpc spinal cord. This phenotype
correlates well with the chick phenotype where downregulat-
ing Pax6 targets in the ventricular zone is sufficient to provoke
premature neuronal differentiation. In both cases, cells in the
ventricular zone express Ngn2 and thus have been committed
to neuronal fate and are ready to differentiate. Then, as Pax6 is
off, there is no impeachment to perform neuronal differentia-
tion. Importantly, we already observed a significant increase of
neuronal differentiation in the neural tube of heterozygous
embryos if compared to wild type littermates. As we did not
detect differences in the level of Ngn2 between these two
670 S. Bel-Vialar et al. / Developmental Biology 305 (2007) 659–673littermates, one interpretation to explain the phenotype would
be that the ratio between Ngn2 and Pax6 would more rapidly
turn in favour of Ngn2 in the heterozygous, thus leading to a
more rapid downregulation of Pax6 and to a premature
neuronal differentiation. This data reveals the importance of
Pax6 dosage in the process of neurogenesis while this dosage
does not seem to influence neuronal specification (Ericson et
al., 1997b).
Regulating Pax6 levels in the spinal cord
Hence, our study highlights the quantitative aspect of Pax6
function in early neurogenesis stages. While low levels of
Pax6 protein are compatible with the proliferation of neural
progenitors, increasing Pax6 in some cells allows them to
leave the cell cycle and reach a “pre-differentiation” state (Fig.
8). Moreover, the number of neurons that are generated in the
first stages of mouse development is inversely correlated with
the level of Pax6 protein. Thus, the amount of Pax6 protein
may allow first to balance the number of proliferating
progenitors with the number of committed precursors and
then the number of differentiating neurons. This emphasis the
need of a tight control of Pax6 levels in coordination with the
growth and maturation of the spinal cord. Pax6 activation is
under the control of the retinoic acid pathway and is able to
autoactivate itself (Diez del Corral et al., 2003; Kleijan et al.,
2004; Novitch et al., 2003). This could be sufficient to reach a
certain amount of Pax6 protein in some cells and predispose
them to neuronal commitment. If Pax6 is totally absent from
neural progenitors, neurogenesis induction occurs anyway
suggesting that other mechanisms are able to compensate the
lack of Pax6 for this step. Lately, Pax6 must be switched off
to permit subsequent differentiation. The first level of
restriction of Pax6 expression arises in the dorso-ventral
axis, via the use of Shh and BMP signalling (Ericson et al.,
1997a; Pituello et al., 1995; Timmer et al., 2002). This way of
decreasing Pax6 levels in some domains is a good way to
progressively release neuronal precursors in coordination with
their specification. In combination with extinguishing Pax6
expression, some Pax6off domain could be kept in a “pre-
differentiated” state for a longer time by the activation by the
same signalling pathways of other factors like Olig2 or
Nkx2.2 playing redundant function. Concerning progenitors in
the Pax6 domain, once they are selected, Pax6 must be
extinguished by another way. We show that high levels of
Ngn2 are capable to downregulate Pax6 expression in few
hours. It has been reported that Pax6 transcript levels are
reduced in the Ngn2 loss of function mutant mouse (Scardigli
et al., 2001). One explanation could be that different doses of
Ngn2 exert different effects on Pax6 regulation by the use of
numerous enhancers in Pax6 regulatory regions, displaying
distinct affinities for Ngn2 protein. It is interesting to note that
this is by such a concentration-dependent regulation that Pax6
is in turn regulating Ngn2 expression (Scardigli et al., 2001).
More likely, as Ngn2 repressor activity has never been
demonstrated, Ngn2 repression of Pax6 transcripts could be
indirect, and go through the action of a transcriptional Ngn2target activated at high concentrations of Ngn2 or by a mean
of a “CBP sequestration model” as it has been recently
proposed for other repressed Ngn2 targets (Ge et al., 2006).
Finally, it appears that this downregulation of Pax6 protein is
part of the proneural activity of Ngn2, as high levels of Ngn2
could not induce neuronal differentiation if Pax6 protein was
maintained. According to that, we detected only few cells co-
expressing Pax6 and Ngn2 proteins and the cells expressing
high levels of Ngn2 protein do not express Pax6 anymore
(Fig. 8B). Similarly, the downstream Pax6 gene FABP7,
which is required to maintain proliferative neuroepithelial
cells (Arai et al., 2005), displays the same patterns of
correlative expression in relation with Ngn2 levels and this
may contribute to the control of neuronal differentiation flow
in this context.
Pax6On is incompatible with neuronal differentiation in the
spinal cord
In conditions of high levels of Pax6 overexpression, the
combined effect on proliferation and neuronal differentiation
leads to a severe defect of neurogenesis. Even if transfection of
low levels of Pax6 gives a milder phenotype, having no impact
on proliferation, Pax6low transgenic cells remain refractory to
neuronal differentiation. As discussed earlier, this construct is
not efficient at inducing Ngn2 and we would not expect
induction of neuronal differentiation. However, we observed the
inverse, i.e., cells maintaining Pax6low do not differentiate. We
detected endogenous cells in the sub-ventricular zone co-
expressing NeuroM and low levels of Pax6 (Fig. 8B). These
Pax6lowNeuroM+ cells retain the expression of Ngn2 (not
shown) suggesting that they are on their way of extinguishing
Pax6 to differentiate and that Ngn2 can initiate the differentia-
tion program even if Pax6 is still present (Fig. 8A). However,
overexpression of Pax6high, while upregulating Ngn2, does not
lead to the upregulation of NeuroM. These data, together with
the fact that all the endogenous HuC/D-differentiated cells are
Pax6off, mean that Pax6 levels start to be lowered to reach the
post-mitotic “NeuroM+” stage and is then switched off to reach
the differentiated stage (Fig. 8A). Thus, once neural cells have
been restricted to a neuronal fate, Pax6 keeps them in an
intermediary state, in which cells progressed toward cell cycle
exit but cannot differentiate, that we termed the “pre-
differentiated state” (Fig. 8). Other examples of disruption of
cell differentiation following Pax6 overexpression has been
reported: In the eye, high levels of Pax6 disrupt normal fiber cell
differentiation and maturation (Duncan et al., 2000). In the rat
hindbrain, efficient electroporation of Pax6 at 11.5 dpc leads to
the downregulation of Islet2 (Takahashi and Osumi, 2002).
Therefore, maintaining neural cells in a “pre-differentiation”
phase could be a general property of Pax6 in the embryonic
CNS. In contrast, in embryonic cortical precursors, astrocytes
isolated from post-natal cortex or adult neural precursors of the
olfactory bulb, overexpression of Pax6 does not inhibit but
rather promote neuronal differentiation (Hack et al., 2005;
Heins et al., 2002). This is in accordance with Pax6 being
maintained in some differentiated neurons in the brain but not
671S. Bel-Vialar et al. / Developmental Biology 305 (2007) 659–673in the embryonic spinal cord. However, most proliferating
progenitors from the adult subventricular zone downregulate
Pax6 to differentiate and only a few cells in the dopaminergic
lineage retain Pax6 expression for their specification (Kohwi
et al., 2005). All together these data suggest that Pax6 acts as a
neurogenic factor in all neural precursors of the adult and
embryonic CNS but in the adult CNS Pax6 is also required in a
subset of young neurons to maintain a specification pressure
toward the dopaminergic fate. Other transcription factors like
Olig2 and Ath5 have been shown to maintain neuronal
precursors in a similar state (Lee et al., 2005; Matter-Sadzinski
et al., 2005). We ourselves tested the effect of Pax3 and
Nkx2.2 in this process. While Pax3 overexpression does not
seem to interfere with neuronal differentiation, Nkx2.2 over-
expression reduces the expression of βTubulin, suggesting that
it is able on its own to regulate some aspects of neuronal
differentiation. The fact that Nkx2.2 is also able to act on
neuronal differentiation may explain why in the Pax6 mutant
mice we do not detect a persistent premature neuronal
differentiation, since Pax6 functions to control the dorsal
limit of Nkx2.2 expression, which expands in its absence
(Briscoe et al., 2000; Ericson et al., 1997b; Lei et al., 2006).
This control by several transcription factors expressed
differentially in the ventricular zone is certainly important in
coordinating neuronal differentiation with the growth of the
embryo and in specifying different neuronal cell types. A
pause in neurogenesis progression may be necessary for the
cell to receive and interpret signals from the environment that
are necessary for the specification of its identity. Several data
suggest that fate specification in the developing and adult CNS
occurs by progressive fate restriction from being multipotent
towards further specified precursors (see Hack et al., 2004). It
has been proposed that the generation of an intermediary set of
precursors restricted towards the generation of neuronal
precursor is of critical importance in order to obtain a high
number of differentiated neurons (Hack et al., 2004). In this
context, the challenge now will be to dissect the mechanisms
by which Pax6 maintains committed neuronal precursors in
this intermediary restricted fate. This could be achieved only
by interfering with transcription factors involved in neuronal
specification but could also go through the regulation of cell
cycle parameters, as it has been suggested in others systems
(Cvekl et al., 1999; Zhou et al., 2005).
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